Polyplus-transfection

company

About

Polyplus-transfection develops, markets and sells solutions for the delivery of nucleic acids in research, bioproduction and therapeutics.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€2.50M
Industries
Biotechnology,Health Care,Life Science,Therapeutics
Founded date
Jan 1, 2001
Number Of Employee
11 - 50
Operating Status
Active

Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€2.50M
Polyplus-transfection has raised a total of €2.50M in funding over 2 rounds. Their latest funding was raised on Jan 11, 2011 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 11, 2011 Series Unknown €2.50M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Polyplus-transfection is funded by 2 investors. Sudinnova and CIC Finance are the most recent investors.
Investor Name Lead Investor Funding Round
Sudinnova Series Unknown
CIC Finance Series Unknown